祥生医疗(688358)披露2025年股权激励计划限制性股票授予结果,12月15日股价上涨0.81%

Core Viewpoint - Xiangsheng Medical (688358) has completed the grant registration of its 2025 restricted stock incentive plan, issuing 150,000 shares at a price of 16.50 yuan per share, which will not affect the company's control [1]. Group 1: Stock Performance - As of December 15, 2025, Xiangsheng Medical's stock closed at 29.82 yuan, up 0.81% from the previous trading day, with a total market capitalization of 3.344 billion yuan [1]. - The stock opened at 29.58 yuan, reached a high of 30.18 yuan, and a low of 29.40 yuan, with a trading volume of 22.3845 million yuan and a turnover rate of 0.67% [1]. Group 2: Incentive Plan Details - The company granted 150,000 restricted shares to 16 incentive recipients, with the stock sourced from a buyback of 148,924 shares and a directed issuance of 1,076 shares [1]. - The total share capital increased from 112,124,537 shares to 112,125,613 shares, with no change in control of the company [1]. - The lock-up period for the shares is set for 12 months and 24 months, with 50% of the shares being released from the lock-up in two phases [1].